BII Biocompatibles

 
TIDMBII 
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 
 
 
 
1. Identity of the issuer or the underlying issuer                        Biocompatibles 
of existing shares to which voting rights are                          International plc 
attached:ii 
 
2 Reason for the notification (please tick the appropriate box or boxes): 
 
An acquisition or disposal of voting rights 
 
An acquisition or disposal of qualifying financial instruments which may result 
in the acquisition of shares already issued to which voting rights are attached 
 
An acquisition or disposal of instruments with similar economic effect to              v 
qualifying financial instruments 
 
An event changing the breakdown of voting rights 
 
Other (please specify): 
 
3. Full name of person(s) subject to the                           Pendragon Capital LLP 
notification obligation:iii 
 
4. Full name of shareholder(s)                                    Pendragon Event Driven 
 (if different from 3.):iv                                                          Fund 
 
5. Date of the transaction and date on 
which the threshold is crossed or                                             18/01/2011 
reached: v 
 
6. Date on which issuer notified:                                             20/01/2011 
 
7. Threshold(s) that is/are crossed or                                                3% 
reached: vi, vii 
 
 
 
 
 
8. Notified details: 
 
A: Voting rights attached to shares viii, ix 
 
Class/   Situation previous              Resulting situation after the triggering transaction 
type of  to the triggering 
shares   transaction 
 
 
if       Number           Number         Number           Number of voting         % of  voting rights x 
possible of               of             of shares        rights 
using    Shares           Voting 
the ISIN                  Rights 
CODE                                     Direct           Direct xi  Indirect xii  Direct  Indirect 
 
 
 
 
 
 
 
 
B: Qualifying Financial Instruments 
 
Resulting situation after the triggering transaction 
 
Type of         Expiration      Exercise/                   Number of voting              % of voting 
financial       date xiii       Conversion Period xiv       rights that may be            rights 
instrument                                                  acquired if the 
                                                            instrument is 
                                                            exercised/ converted. 
 
 
 
 
 
C: Financial Instruments with similar economic effect to Qualifying Financial 
Instruments xv, xvi 
 
Resulting situation after the triggering transaction 
 
Type of    Exercise price Expiration    Exercise/         Number of voting rights   % of voting rights 
financial                 date xvii     Conversion period instrument refers to      xix, xx 
instrument                              xviii 
 
 
                                                          1,226,569                 Nominal Delta 
CFD 
                                                                                    3.11% 
 
 
 
Total (A+B+C) 
 
Number of voting rights                         Percentage of voting rights 
 
1,226,569                                       3.11% 
 
 
 
 
 
9. Chain of controlled undertakings through which the voting rights and/or the 
financial instruments are effectively held, if applicable: xxi 
 
 
 
 
 
 
 
Proxy Voting: 
 
10. Name of the proxy holder: 
 
11. Number of voting rights proxy holder will cease 
to hold: 
 
12. Date on which proxy holder will cease to hold 
voting rights: 
 
 
 
 
13. Additional information: 
 
14. Contact name:                                                            Kathy Samii 
 
15. Contact telephone number:                                              020 7355 0420 
 
 
 
 
 
 
END 
 

Biocompatibles (LSE:BII)
Historical Stock Chart
From Jun 2024 to Jul 2024

Biocompatibles (LSE:BII)
Historical Stock Chart
From Jul 2023 to Jul 2024